DTL
KNSA icon

Dynamic Technology Lab’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Dynamic Technology Lab’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$214K Buy
+3,349
New +$174K 0.05% 539
2024
Q1 		– Sell
-12,160
Closed -$213K – 1248
2023
Q4 		$213K Buy
+12,160
New +$200K 0.02% 858
2023
Q3 		– Sell
-19,081
Closed -$269K – 1142
2023
Q2 		$269K Sell
19,081
-10,904
-36% -$146K 0.03% 742
2023
Q1 		$323K Buy
+29,985
New +$395K 0.03% 770

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Dynamic Technology Lab's KNSA Position: Q2 2026 in Review

Dynamic Technology Lab opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q2 2026: 3,349 shares worth $214K. The stake represents 0.05% of the portfolio and ranks #539 among its holdings. This is a return to the name: Dynamic Technology Lab previously reported a position in KNSA as recently as Q4 2023.

Dynamic Technology Lab first reported a position in KNSA in Q1 2023 and has held it in 4 quarters since. The position peaked at $323K in Q1 2023. 267 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Dynamic Technology Lab held 3,349 shares of Kiniksa Pharmaceuticals worth $214K as of Q2 2026.
  • Kiniksa Pharmaceuticals was a new Dynamic Technology Lab position in Q2 2026.
  • Kiniksa Pharmaceuticals made up 0.05% of Dynamic Technology Lab's portfolio in Q2 2026, its #539 holding.
  • Dynamic Technology Lab first reported a position in Kiniksa Pharmaceuticals in Q1 2023 and has held it in 4 quarters since.
  • Dynamic Technology Lab's Kiniksa Pharmaceuticals position peaked at $323K in Q1 2023.
  • 267 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Dynamic Technology Lab's 13F filing for Q2 2026, filed 13 Aug 2026.